AKT1 and lung carcinoma: In their in vitro and in vivo studies, they reported that this peptide can inhibit cell proliferation of KRAS-mutated A549 lung cancer cells and significantly suppress tumor growth in A549 xenograft mice by activating PKB/ERK/SMAD4 pathways.